Hyperpolarized Carbon-13 Pyruvate
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hyperpolarized Carbon-13 Pyruvate, covering 2025-08-26 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors [Phase 1]